It is the policy of the MN Network of Hospice & Palliative Care and the Minnesota Medical Association (MMA) to ensure balance, independence, objectivity, and scientific rigor in CME activities. To comply with theStandards for Integrity and Independence of the Accreditation Council for Continuing Medical Education (ACCME), planning committee members and faculty are required to disclose all financial relationships they have with an ineligible company. Disclosed relationships are thoroughly evaluated and all potential conflicts of interest are mitigated appropriately. No one with the ability to control content of this activity has a relevant financial relationship with an ineligible company.
This activity is provided by Minnesota Network of Hospice and Palliative Care jointly with Minnesota Medical Association. This nursing continuing professional development activity was approved by the Wisconsin Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
In order to earn contact hours for this event, regardless of discipline, conference attendees must attend one or more live sessions in their entirety and complete a post-event evaluation.
Disclosures for Faculty and Planners
The members of the faculty and planning committee for the 2025 MNHPC Conference have disclosed all relevant financial relationships with ineligible companies. Faculty members have committed to uphold the ACCME standards regarding CME activities and to ensure that clinical recommendations are based on the best available evidence or are consistent with generally accepted medical practice. Please indicate in the comments section of the post-conference evaluation form whether you detect any instances of bias toward products manufactured by an ineligible company.
No relevant financial relationships with ineligible companies were disclosed for faculty or planners of the 2025 MNHPC Conference.
Faculty members have committed to upholding ACCME standards regarding educational activity and to ensuring that clinical recommendations are based on the best available evidence or are consistent with
- Ineligible Company: Those whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.
- The ACCME defines "'relevant' financial relationships” as financial relationships in any amount occurring within the past 24 months that could potentially create a conflict of interest.
generally accepted medical practice. Please indicate in the comments section of the post-conference evaluation form whether you detect any instances of bias toward products manufactured by an ineligible company.